scispace - formally typeset
R

Ricardo Bentes Azevedo

Researcher at University of Brasília

Publications -  252
Citations -  6755

Ricardo Bentes Azevedo is an academic researcher from University of Brasília. The author has contributed to research in topics: Cancer & Photodynamic therapy. The author has an hindex of 43, co-authored 229 publications receiving 5514 citations. Previous affiliations of Ricardo Bentes Azevedo include University of São Paulo & Federal University of Rio de Janeiro.

Papers
More filters
Journal ArticleDOI

An updated overview on the development of new photosensitizers for anticancer photodynamic therapy

TL;DR: This review presents an overview on the classical photosensitizers and the most significant recent advances in the development of PS with regard to their potential application in oncology.
Journal ArticleDOI

Rapid renewal of auditory hair bundles.

TL;DR: Stereocilia, also known as hair bundles, are mechanosensitive organelles of the sensory hair cells of the inner ear that can detect displacements on a nanometre scale and are supported by a rigid, dense core of actin filaments.
Journal ArticleDOI

Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice.

TL;DR: Magnetic resonance was used to investigate the kinetic disposition of magnetite nanoparticles from the blood circulation after intravenous injection of Magnetite-based dextran-coated magnetic fluid in female Swiss mice, finding the system recovers the linearity due to the demagnetizing field effect alone.
Journal ArticleDOI

Synthesis and characterization of size-controlled cobalt-ferrite-based ionic ferrofluids

TL;DR: In this paper, the size controlled synthesis of cobalt-ferrite nanoparticles, their passivation and peptization as stable ferrofluids, and the anomalous diffusion has been used to explain the nanoparticle size control mechanism.
Journal ArticleDOI

Nanographene oxide-methylene blue as phototherapies platform for breast tumor ablation and metastasis prevention in a syngeneic orthotopic murine model.

TL;DR: The nanographene oxide-methylene blue platform (NanoGO-MB) was used to promote tumor ablation in combination with photodynamic and photothermal therapies against a syngeneic orthotopic murine breast cancer model and confirmed that the combined therapies were able to prevent tumor regrowth and liver, lung and spleen metastasis.